Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients

Inclusion Criteria: * Male or Female 18 to 85 years of age * NDD-CKD Patients * TSAT \</= 25% * Hgb \</= 11.5 * Ferritin \</= 300 * HD-CKD Patients * TSAT \</= 30% * Hgb \</= 12 * Ferritin \</= 500 Exclusion Criteria: * Previous participation in a FCM trial * Known Hypersensitivity to FCM * History of anemia other that anemia due to chronic renal failure * Current history of GI bleeding * Received IV Iron within the last 30 Days * Anticipated need for surgery * Malignancy history * AST or ALT greater than normal * Received an investigational drug within 30 days of screening * Pregnant or sexually active females who are not willing to use an effective form of birth control